PRT2527
PRT2527-02
Phase 1 small_molecule completed
Quick answer
PRT2527 for Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL) is a Phase 1 program (small_molecule) at Prelude Therapeutics Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Prelude Therapeutics Inc
- Indication
- Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed